スタッフ ログイン
Japanese |
English
ご質問・ご要望
一覧
検索
生物種別閲覧
登録
統計情報
検索
ホーム
一覧
論文
特許
論文 - 一覧
«
»
47 Hits
検索条件 : 絞込み (MeSH = CD8-Positive T-Lymphocytes / immunology)
生物種
リソース名
RRC ID
タイトル
ジャーナル
公開日
外部リンク
ヒト・動物細胞
LM8(RCB1450)
76356
Enhancement of antitumor immunity by combining anti-cytotoxic T lymphocyte antigen-4 antibodies and cryotreated tumor lysate-pulsed dendritic cells in murine osteosarcoma.
Oncol Rep
2013-3-1
Pubmed
Full text
ヒト・動物細胞
LM8(RCB1450)
76355
Anti-TGF-β antibody combined with dendritic cells produce antitumor effects in osteosarcoma.
Clin Orthop Relat Res
2012-8-1
Pubmed
Full text
ヒト・動物細胞
B16
73321
Induction of antigen-specific immune responses against malignant brain tumors by intramuscular injection of sindbis DNA encoding gp100 and IL-18.
DNA Cell Biol
2005-5-1
Pubmed
Full text
ヒト・動物細胞
293T(RCB2202)
73014
Blocking PD-L1-PD-1 improves senescence surveillance and ageing phenotypes.
Nature
2022-11-1
Pubmed
Full text
ヒト・動物細胞
ST2(RCB0224)
73004
Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki forest virus-mediated complementary DNA.
J Neurosurg
2001-3-1
Pubmed
Full text
ヒト・動物細胞
B16F10(RCB2630)
72512
Intratumoral CD4+ T lymphodepletion sensitizes poorly immunogenic melanomas to immunotherapy with an OX40 agonist.
J Invest Dermatol
2014-7-1
Pubmed
Full text
ヒト・動物細胞
OP9(RCB1124)
,
OP9/G-DLL1(RCB2925)
72500
In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.
J Immunother Cancer
2021-5-1
Pubmed
Full text
ヒト・動物細胞
YAC-1(RCB1165)
72294
Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model.
J Immunother
2001-1-1
Pubmed
ヒト・動物細胞
OS-RC-2(RCB0735)
69471
Nanoparticle-Mediated Delivery of 2-Deoxy-D-Glucose Induces Antitumor Immunity and Cytotoxicity in Liver Tumors in Mice.
Cell Mol Gastroenterol Hepatol
2021-1-1
Pubmed
Full text
ヒト・動物細胞
SKW-3(RCB1168)
68938
Identification of TCR repertoires in functionally competent cytotoxic T cells cross-reactive to SARS-CoV-2.
Commun Biol
2021-12-2
Pubmed
Full text
ヒト・動物細胞
PC-9(RCB4455)
,
RERF-LC-AI(RCB0444)
67012
11β hydroxysteroid dehydrogenase 1: a new marker for predicting response to immune-checkpoint blockade therapy in non-small-cell lung carcinoma.
Br J Cancer
2020-7-1
Pubmed
Full text
ヒト・動物細胞
iPS-MEF-Ng-20D-17(APS0001)
66888
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice.
J Vis Exp
2019-9-25
Pubmed
Full text
ヒト・動物細胞
TE-1(RCB1894)
65483
Prognostic Significance of PD-1, PD-L1 and CD8 Gene Expression Levels in Gastric Cancer.
Oncology
2020-1-1
Pubmed
Full text
ヒト・動物細胞
LAG(RCB2758)
,
LM8(RCB1450)
,
NFSa Y83(RCB0282)
,
KUM5(RCB2322)
65454
CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment.
Mol Cancer Ther
2021-8-1
Pubmed
Full text
ヒト・動物細胞
B16F10(RCB2630)
63485
Circulating nano-particulate TLR9 agonist scouts out tumor microenvironment to release immunogenic dead tumor cells.
Oncotarget
2016-8-2
Pubmed
Full text
ヒト・動物細胞
LM8(RCB1450)
62778
Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapy.
Oncotarget
2016-3-29
Pubmed
Full text
ヒト・動物細胞
GCIY(RCB0555)
61722
Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique.
Int J Oncol
2006-9-1
Pubmed
実験動物マウス
RBRC01544
58614
Immunotherapeutic Blockade of CD47 Inhibitory Signaling Enhances Innate and Adaptive Immune Responses to Viral Infection.
Cell Rep
2020-4-14
Pubmed
Full text
遺伝子材料
B6N Mouse BAC clone (RDB07573)
,
B6Ng01- 240G08
58233
Glucocorticoids potentiate the inhibitory capacity of programmed cell death 1 by up-regulating its expression on T cells.
J Biol Chem
2019-12-27
Pubmed
Full text
ヒト・動物細胞
SLVL(RCB1702)
54875
Combination lenalidomide-rituximab immunotherapy activates anti-tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphoma.
Br J Haematol
2019-4-1
Pubmed
Full text